Oppenheimer & Co. Inc. Purchases 10,391 Shares of Amdocs Limited (NASDAQ:DOX)

Oppenheimer & Co. Inc. lifted its position in shares of Amdocs Limited (NASDAQ:DOXFree Report) by 48.5% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 31,796 shares of the technology company’s stock after buying an additional 10,391 shares during the quarter. Oppenheimer & Co. Inc.’s holdings in Amdocs were worth $2,795,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of DOX. Avantax Advisory Services Inc. purchased a new stake in Amdocs during the 3rd quarter valued at approximately $508,000. J.P. Morgan Private Wealth Advisors LLC increased its holdings in Amdocs by 1.7% in the 3rd quarter. J.P. Morgan Private Wealth Advisors LLC now owns 22,075 shares of the technology company’s stock valued at $1,865,000 after acquiring an additional 367 shares during the last quarter. Amalgamated Bank increased its holdings in Amdocs by 32.0% in the 3rd quarter. Amalgamated Bank now owns 26,734 shares of the technology company’s stock valued at $2,259,000 after acquiring an additional 6,482 shares during the last quarter. Atria Wealth Solutions Inc. boosted its holdings in shares of Amdocs by 65.7% during the 3rd quarter. Atria Wealth Solutions Inc. now owns 13,184 shares of the technology company’s stock valued at $1,118,000 after purchasing an additional 5,227 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its position in shares of Amdocs by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 166,245 shares of the technology company’s stock valued at $14,046,000 after purchasing an additional 1,912 shares in the last quarter. Institutional investors own 92.02% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Robert W. Baird decreased their target price on Amdocs from $97.00 to $90.00 and set a “neutral” rating on the stock in a research report on Thursday, May 9th. StockNews.com downgraded Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, March 15th. Finally, Citigroup reduced their price target on shares of Amdocs from $105.00 to $100.00 and set a “buy” rating on the stock in a research report on Thursday, May 9th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $104.83.

Check Out Our Latest Report on DOX

Amdocs Price Performance

Shares of Amdocs stock opened at $76.49 on Friday. The stock has a 50 day moving average price of $83.51 and a 200-day moving average price of $87.38. Amdocs Limited has a one year low of $76.24 and a one year high of $99.75. The stock has a market cap of $8.99 billion, a price-to-earnings ratio of 17.19, a price-to-earnings-growth ratio of 1.35 and a beta of 0.74. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.32 and a current ratio of 1.32.

Amdocs (NASDAQ:DOXGet Free Report) last posted its quarterly earnings data on Wednesday, May 8th. The technology company reported $1.38 EPS for the quarter, missing the consensus estimate of $1.43 by ($0.05). Amdocs had a return on equity of 17.85% and a net margin of 10.62%. The firm had revenue of $1.25 billion for the quarter, compared to analysts’ expectations of $1.25 billion. Equities analysts expect that Amdocs Limited will post 5.72 EPS for the current year.

Amdocs Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be paid a $0.479 dividend. This represents a $1.92 annualized dividend and a yield of 2.50%. The ex-dividend date of this dividend is Friday, June 28th. Amdocs’s payout ratio is currently 43.15%.

Amdocs Company Profile

(Free Report)

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

See Also

Institutional Ownership by Quarter for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.